AU Patent

AU3247799A — Glp-1 derivatives of glp-1 and exendin with protracted profile of action

Assigned to Novo Nordisk AS · Expires 1999-09-15 · 27y expired

What this patent protects

Patent listed against dasiglucagon-hydrochloride.

Drugs covered by this patent

dasiglucagon-hydrochloride (DASIGLUCAGON HYDROCHLORIDE)

Patent Metadata

Patent number: AU3247799A
Jurisdiction: AU
Classification: —
Expires: 1999-09-15
Drug substance claim: No
Drug product claim: No
Assignee: Novo Nordisk AS
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.